We've found
21,509 Breast Cancer
clinical trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling,
Phase
I
Updated: 11/5/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling,
Phase
I
Updated: 11/5/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Nonmyeloablative Allogeneic Transplant
Status: Enrolling
Updated: 12/5/2013
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Protein Expression in Predicting Response to Treatment Using Tumor Tissue Samples From Women With Stage I, Stage II, or Stage IIIA Breast Cancer Treated on Clinical Trial SWOG-9313
Status: Enrolling
Updated: 10/14/2010
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
Status: Enrolling
Updated: 7/9/2013
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil
Status: Enrolling
Updated: 6/16/2011
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Statins and Breast Cancer Biomarkers
Status: Enrolling,
Phase
II
Updated: 2/10/2010
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Statins and Breast Cancer Biomarkers
Status: Enrolling,
Phase
II
Updated: 2/10/2010
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Axillary Lymph Node Preservation Surgery in Reducing Lymphedema in Patients With Breast Cancer
Status: Enrolling,
Phase
I, II
Updated: 1/21/2014
Click here to add this to my saved trials
Breast Abnormality Clinical Trial
Circulating Tumor Cells (CTCs): A Potential Screening Test for Clinically Undetectable Breast Carcinoma
Status: Enrolling
Updated: 3/24/2011
Click here to add this to my saved trials
Lymphedema Clinical Trial
International Lymphatic Disease and Lymphedema Registry
Status: Enrolling,
Phase
Updated: 2/28/2018
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
We've found
21,509 Breast Cancer
clinical trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/5/2014
Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling,
Phase
I
Updated: 11/5/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/5/2014
Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Status: Enrolling,
Phase
I
Updated: 11/5/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/5/2013
Nonmyeloablative Allogeneic Transplant
Status: Enrolling
Updated: 12/5/2013
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 10/14/2010
Protein Expression in Predicting Response to Treatment Using Tumor Tissue Samples From Women With Stage I, Stage II, or Stage IIIA Breast Cancer Treated on Clinical Trial SWOG-9313
Status: Enrolling
Updated: 10/14/2010
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 7/9/2013
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
Status: Enrolling
Updated: 7/9/2013
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 6/16/2011
Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil
Status: Enrolling
Updated: 6/16/2011
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 2/10/2010
Statins and Breast Cancer Biomarkers
Status: Enrolling,
Phase
II
Updated: 2/10/2010
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 2/10/2010
Statins and Breast Cancer Biomarkers
Status: Enrolling,
Phase
II
Updated: 2/10/2010
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 1/21/2014
Axillary Lymph Node Preservation Surgery in Reducing Lymphedema in Patients With Breast Cancer
Status: Enrolling,
Phase
I, II
Updated: 1/21/2014
Click here to add this to my saved trials
Breast Abnormality Clinical Trial
Updated: 3/24/2011
Circulating Tumor Cells (CTCs): A Potential Screening Test for Clinically Undetectable Breast Carcinoma
Status: Enrolling
Updated: 3/24/2011
Click here to add this to my saved trials
Lymphedema Clinical Trial
Updated: 2/28/2018
International Lymphatic Disease and Lymphedema Registry
Status: Enrolling,
Phase
Updated: 2/28/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials